skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:062640/0056   Pages: 5
Recorded: 02/05/2023
Attorney Dkt #:CRVC.P0231/32/35/37/39/41
Conveyance: CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Total properties: 13
1
Patent #:
11478552
Issue Dt:
10/25/2022
Application #:
16308632
Filing Dt:
12/10/2018
Publication #:
US20200179526
Pub Dt:
06/11/2020
Title:
HYBRID CARRIERS FOR NUCLEIC ACID CARGO
2
Patent #:
NONE
Issue Dt:
Application #:
16326281
Filing Dt:
02/18/2019
Publication #:
US20190185859
Pub Dt:
06/20/2019
Title:
RNA FOR CANCER THERAPY
3
Patent #:
NONE
Issue Dt:
Application #:
16345299
Filing Dt:
04/26/2019
Publication #:
US20200163878
Pub Dt:
05/28/2020
Title:
LIPID NANOPARTICLE MRNA VACCINES
4
Patent #:
11464836
Issue Dt:
10/11/2022
Application #:
16466630
Filing Dt:
06/04/2019
Publication #:
US20190343933
Pub Dt:
11/14/2019
Title:
RNA FOR TREATMENT OR PROPHYLAXIS OF A LIVER DISEASE
5
Patent #:
11141476
Issue Dt:
10/12/2021
Application #:
16471539
Filing Dt:
06/19/2019
Publication #:
US20190351048
Pub Dt:
11/21/2019
Title:
MERS CORONAVIRUS VACCINE
6
Patent #:
11464847
Issue Dt:
10/11/2022
Application #:
16471544
Filing Dt:
06/19/2019
Publication #:
US20190351044
Pub Dt:
11/21/2019
Title:
LASSA VIRUS VACCINE
7
Patent #:
NONE
Issue Dt:
Application #:
16494422
Filing Dt:
09/16/2019
Publication #:
US20200085944
Pub Dt:
03/19/2020
Title:
RNA VACCINE AND IMMUNE CHECKPOINT INHIBITORS FOR COMBINED ANTICANCER THERAPY
8
Patent #:
NONE
Issue Dt:
Application #:
17142731
Filing Dt:
01/06/2021
Publication #:
US20210251898
Pub Dt:
08/19/2021
Title:
LIPID NANOPARTICLE MRNA VACCINES
9
Patent #:
11865084
Issue Dt:
01/09/2024
Application #:
17467632
Filing Dt:
09/07/2021
Publication #:
US20210401971
Pub Dt:
12/30/2021
Title:
MERS CORONAVIRUS VACCINE
10
Patent #:
NONE
Issue Dt:
Application #:
17571893
Filing Dt:
01/10/2022
Publication #:
US20220396796
Pub Dt:
12/15/2022
Title:
RNA FOR CANCER THERAPY
11
Patent #:
NONE
Issue Dt:
Application #:
17930062
Filing Dt:
09/06/2022
Publication #:
US20230158126
Pub Dt:
05/25/2023
Title:
RNA FOR TREATMENT OR PROPHYLAXIS OF A LIVER DISEASE
12
Patent #:
NONE
Issue Dt:
Application #:
17930065
Filing Dt:
09/06/2022
Publication #:
US20230181713
Pub Dt:
06/15/2023
Title:
LASSA VIRUS VACCINE
13
Patent #:
NONE
Issue Dt:
Application #:
18048423
Filing Dt:
10/20/2022
Publication #:
US20230302146
Pub Dt:
09/28/2023
Title:
HYBRID CARRIERS FOR NUCLEIC ACID CARGO
Assignor
1
CUREVAC AG
Exec Dt:
09/26/2022
Assignee
1
CUREVAC SE
FRIEDRICH-MIESCHER-STRASSE 15
TÜBINGEN, GERMANY 72076
Correspondence name and address
PARKER HIGHLANDER PLLC, AMANDA SCHNEPP
1120 S. CAPITAL OF TEXAS HWY.
BUILDING ONE, SUITE 200
AUSTIN, TX 78746

Search Results as of: 06/25/2024 01:32 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT